In support of the government’s policy to speed up investment in Taiwan and to build a platform for exchange between overseas compatriot entrepreneurs and the domestic medical industry, the Overseas Community Affairs Council (OCAC) held the 2019 OCAC Taiwan Medical Industry Investment Program for Overseas Compatriot Entrepreneurs June 24-28. 16 overseas compatriot entrepreneurs from 11 regions in eight countries (Malaysia, the Philippines, Brunei, Vietnam, Japan, Indonesia, the US and Australia) who are interested in investing in the domestic medical industry, cooperating with related domestic enterprises or who can assist Taiwan’s medical industry enterprises expand their overseas markets came to Taiwan to explore business opportunities. OCAC Minister Wu Hsin-hsing hosted the opening ceremony on June 24 at which we welcomed participants; a general discussion meeting was hosted by Director General of the OCAC Department of Business Affairs Wong Shu-hwa on June 28 in which related suggestions were made.
Visits were arranged to the Ministry of Health and Welfare, Hsinchu Biomedical Science Park Incubation Center, SMEA and to five outstanding domestic medical industry enterprises, namely Sofiva, Avalue Technology, Ko Da Pharmaceutical, IMEDIPLUS Inc., Yen Chen Machinery Co. Ltd., and Chang Bing Show Chwan Memorial Hospital’s Show Chwan Asia-Pacific Incubation Center. During the visits, participants interacted with senior managers and engaged in business opportunity exchange, obtained an understanding of the Taiwan medical industry situation, and increased the understanding of the advantages and resources of Taiwan’s medical industry and Taiwan’s investment environment of the overseas compatriot entrepreneurs taking part in the Program. One business opportunity matching meeting was also held in which participants had exchanges with representatives of 15 domestic medical industry enterprises; a general discussion meeting was held at noon on June 28 in which participants all said they had gained a lot from the Program. They said it will be of substantial help with their overseas business operations and also expressed a willingness to assist Taiwan’s medical industry companies develop in their places of residence, boosting the medical industry’s domestic and overseas investment momentum.